Skip to main content
Clinical Trials/NCT02829593
NCT02829593CompletedNot Applicable

Measurement of Glucose Metabolism in Humans Using Magnetic Resonance at 7 Tesla: Effect of Recurrent Hypoglycemia on Hypothalamic GABA

University of Minnesota1 site in 1 country34 target enrollmentStarted: October 31, 2019Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
34
Locations
1
Primary Endpoint
Change in Euglycemic GABA level in hypothalamus using MRI

Study Overview

Brief Summary

You are invited to participate in a study designed to investigate the effects of diabetes mellitus, high and low glucose, and high blood insulin on the brain. You were selected as a possible participant because you fit into one of the following categories. a) you are either healthy and competent, are not pregnant and you have no known medical disease and therefore your glucose metabolism will be typical of a normal person, or b) you have diabetes.

Detailed Description

Glucose is a major fuel for most organs in the human body, particularly the brain. How and where the body uses glucose is regulated by a number of hormones, for instance insulin and glucagon. In a number of diseases, in particular diabetes mellitus, the glucose supply to the brain may be different than normal, which may be a cause for reduced glucose awareness.

The purpose of this study is to determine the effects of altered glucose metabolism on the brain. For example, patients with long duration diabetes mellitus lose their ability to secrete the hormones necessary to protect them against hypoglycemia, which may be due to alterations in glucose availability to the human brain.

To measure these effects, we will use intravenous infusions of glucose and insulin.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •well controlled type 1 diabetes (hemoglobin A1c <7.5%)
  • •age 18-65
  • •healthy controls

Exclusion Criteria

  • •history of stroke, seizures, neurosurgical procedures, or arrhythmias
  • •use of drugs that can alter GABA metabolism (such as benzodiazepines).
  • •Subjects must also meet requirements for a study in the magnet, which includes weight less than 300 lbs and the absence of metallic substances in their body.

Arms & Interventions

type 1 diabetes

Experimental

type 1 diabetes >5 years duration

Intervention: hypoglycemia (low blood sugar) and MRI (Other)

healthy controls

Placebo Comparator

Intervention: hypoglycemia (low blood sugar) and MRI (Other)

Outcomes

Primary Outcomes

Change in Euglycemic GABA level in hypothalamus using MRI

Time Frame: Baseline to 2 month

MRI measurement of GABA in the hypothalamus

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials